Profusa PFSA
NASDAQ PFSA
$5.46 -2.11 (-27.87%)
At close: Aug 21, 2026 · 4:00 PM EDT

Profusa (PFSA) Return on Invested Capital (2022 - 2025)

Profusa (PFSA) posted quarterly Return on Invested Capital of 0.0% for Q2 2025, up 33.75% quarter-over-quarter from 0.01% in Q1 2025.

Profusa (PFSA) Return on Invested Capital (2022 - 2025) Analysis & Trends

Profusa's Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.0% for Q2 2025.

  • In Q2 2025, Return on Invested Capital changed N/A year-over-year to 0.0%; the TTM figure through Jun 2025 stood at 0.0% (changed N/A YoY), while the FY2022 annual figure was 0.9%, changed N/A from the prior year.
  • Return on Invested Capital for Q2 2025 stood at 0.0%, up from 0.01% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.0% in Q2 2025, with the low at 0.42% in Q4 2022.
  • The 3-year median for Return on Invested Capital is 0.31% (2023), against an average of 0.23%.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 0.01%
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 0.01%
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 0.01%
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 0.00%
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 0.01%
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 0.00%
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 0.04%
10 Profusa 92,085.85 -282,914.15 - -

Historic Data

Download Data
DateValue
Jun 30, 2025 0.00%
Mar 31, 2025 -0.01%
Sep 30, 2023 -0.31%
Jun 30, 2023 -0.34%
Mar 31, 2023 -0.30%
Dec 31, 2022 -0.42%